Search Results 3201-3210 of 16426 for Chiari malformation
Christopher K. Pierret, Ph.D., and his colleagues are interested in many areas of science as they directly relate to their local and global community. The ...
... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A ...
... Syndrome Assess the Long-term Safety and Effecticeness of Osilodrostat in Patients with Endogenous Cushing's Syndrome NCT ID: POC ID: CLS-20542689; Title ...
... Syndrome of Menopause with Platelet Rich Plasma (PRP) in Women with a History of Breast Cancer (PRP for GSM) Treatment of Genitourinary Syndrome with ...
... Syndrome Using InBody 770® Hydration Status of Patients Suffering from Postural Orthostatic Tachycardia Syndrome Using InBody 770® NCT ID: POC ID: CLS ...
... Syndrome Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and ... Syndrome NCT ID: NCT01637272 POC ID: CLS-20118819; Title: Feasibility ...
At Mayo Clinic, patients with autoimmune disorders, including Crohn's disease, scleroderma and multiple sclerosis, also may be eligible for an autologous bone ...
- Malabsorption syndrome within 30 days prior to randomization - Patient must not be pregnant or breast-feeding due to the potential harm to an unborn fetus ...
The Center for Clinical and Translational Science (CCaTS) Office of Research Subject Recruitment connects research teams with potential study participants.
... Syndrome in Children and Adults, With Optional Open-Label Extension Investigate the Efficacy and Safety of Carisbamate (YKP509) as Adjunctive Treatment for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.